Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D004878:Ergotamine / Q000627:therapeutic use; D005260:Female; D006261:Headache / Q000517:prevention & control*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D012702:Serotonin Antagonists; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D014653:Vascular Headaches / Q000517:prevention & control
D006634:Histamine H1 Antagonists; D010919:Placebos; D012702:Serotonin Antagonists; D013876:Thiophenes; D000109:Acetylcholine; D004878:Ergotamine